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Background: Autistic spectrum disorders (ASDs) are a family of neurodevelopmental disorders with strong genetic
components. Recent studies have shown that copy number variations in dosage sensitive genes can contribute
significantly to these disorders. One such gene is the transcription factor MECP2, whose loss of function in females
results in Rett syndrome, while its duplication in males results in developmental delay and autism.
Case presentation: Here, we identified a Chinese family with two brothers both inheriting a 2.2 Mb MECP2-
containing duplication (151,369,305 – 153,589,577) from their mother. In addition, both brothers also had a 213.7 kb
duplication on Chromosome 2, inherited from their father. The older brother also carried a 48.4 kb duplication on
Chromosome 2 inherited from the mother, and a 8.2 kb deletion at 11q13.5 inherited from the father. Based on the
published literature, MECP2 is the most autism-associated gene among the identified CNVs. Consistently, the boys
displayed clinical features in common with other patients carrying MECP2 duplications, including intellectual
disability, autism, lack of speech, slight hypotonia and unsteadiness of movement. They also had slight dysmorphic
features including a depressed nose bridge, large ears and midface hypoplasia. Interestingly, they did not exhibit
other clinical features commonly observed in American-European patients with MECP2 duplication, including
recurrent respiratory infections and epilepsy.
Conclusions: To our knowledge, this is the first identification and characterization of Chinese Han patients with
MECP2-containing duplications. Further cases are required to determine if the above described clinical differences
are due to individual variations or related to the genetic background of the patients.
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Autism spectrum disorders (ASDs) are neurodevelop-
mental disorders with complex etiology and strong gen-
etic basis, characterized by impaired communication,
reduced social interaction, and stereotyped and/or repeti-
tive behavior [1-4]. Over the past decade, an emergent* Correspondence: xuxiu@shmu.edu.cn; yuxiang@ion.ac.cn
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reproduction in any medium, provided the orfeature regarding the genetics of ASD is the importance
of gene dosage, where both loss and gain of function of a
gene can result in autistic phenotypes [4,5]. A prominent
example is the Methyl-CpG-binding Protein 2 gene
(MECP2; MIM: 300005), located at Xq28. Loss of func-
tion of one copy of MECP2 leads to Rett syndrome (RTT;
MIM 312750), a progressive neurodevelopmental dis-
order characterized by loss of motor skills and communi-
cation abilities, as well as stereotypic hand movements
and other autistic features, occurring in 1:10,000 girls
[6-9]. More recently, duplication of the MECP2 gene has
been found in boys with developmental delay,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[10-28]. Core features of the syndrome included infantile
hypotonia, mild dysmorphic features, developmental
delay, intellectual disability, abnormal movement and
absent to minimal speech. Although not all studies
examined autistic characteristics, when the examinations
were carried out, autistic phenotypes were prominent
among patients with MECP2 duplication [15,21,23,29]. In
fact, of 8 boys evaluated using the Autism Diagnostic
Observation Schedule (ADOS) in one study, 7 (88%)
exceeded the cutoff score for autism, while the remaining
one exceeded the score for ASD [23]. Thus altering the
gene dosage of MECP2 by both deletion and duplication
can generate autistic phenotypes. Corroborating these
clinical findings, similarities in phenotypes, including aut-
istic features, were observed both in mouse models of
MECP2 deletions and duplications [30-34].
Whether MECP2 duplication is a cause of intellectual
disability and/or autism in the Chinese Han population
is unknown. A previous study screening 82 Chinese Han
boys diagnosed with autism using real-time quantitative
polymerase chain reaction (qPCR) failed to identify dele-
tions or duplications in MECP2 [35]. Since the sample
size was small, the question of whether MECP2 duplica-
tion is present in Chinese patients diagnosed with aut-
ism required further study. Here, we report two brothers
diagnosed with autistic disorder carrying duplication in
MECP2, inherited from their mother. Detailed examin-
ation, medical history inquiry and characterization by
ADOS showed that these boys shared many characteris-
tics with previously reported patients carrying duplica-
tion encompassing the MECP2 gene [10-28], including
autism, intellectual disability, hypotonia and mild dys-
morphic features, but not recurrent respiratory infec-
tions or epilepsy. Genome-wide CNV scan using Agilent
1 M comparative genomic hybridization (CGH) micro-
array showed that both brothers carried a 2.22 Mb
MECP2-duplication containing CNV, inherited from
their mother. To our knowledge, this is the first reportFigure 1 Identification of two brothers with inherited MECP2 duplicat
pedigree symbols are used. B. CNV screening using Accucopy kit for all me
P47A is a boy with normal MECP2 gene dosage. Males are represented byand characterization of MECP2 duplication patients
from the Chinese Han population.
Case presentation
In a screen for CNVs in MECP2 carried out for children
diagnosed with ASD at the Children’s Hospital of Fudan
University, 53 unrelated male subjects diagnosed with
ASD using DSM-IV (average age at first diagnosis:
4.15 ± 0.27 years) were tested. One boy (P01A) was iden-
tified with a MECP2 duplication. This patient also had
an older brother with intellectual disability and no
speech. The patient, his older brother and both parents
were then all assayed for CNVs in MECP2 using an
Accucopy kit, a multiplex competitive amplification-
based method (Genesky Biotechnologies Inc., Shanghai,
China, see Additional file 1 for details) [36]. The older
brother (P01B) was found to have two copies of MECP2,
the father (P01C) had a single copy, while the mother
(P01D) carried three copies (Figure 1A, B). Control males
and females carried one or two copies ofMECP2, respect-
ively, as expected (Figure 1B). These results, further con-
firmed using standard real-time qPCR (Figure 1C),
showed that both brothers carried MECP2 duplication
inherited from the mother.
Clinical summary
Detailed clinical data was gathered from the family. The
pedigree is shown in Figure 1A. A girl (G2 P2), born be-
tween the two brothers, was born prematurely at 30 weeks,
likely because the mother was startled. She died one month
after birth. It was noted that she fed very poorly, although
her body weight did increase slightly. On the day before she
died, she did not feed at all. The cause of death was un-
known, as no medical examinations were carried out. It is
possible that she also carried the MECP2-containing dupli-
cation (no DNA sample available). Although DNA from
other members of the mother’s family could not be
obtained, the pedigree showed that the mother was the
youngest of 5 children, with 2 healthy brothers, and oneion in Chinese autism patients. A. Pedigree of family P01, standard
mbers of family P01. C. Confirmation of results using real-time qPCR.
blue bars, and females by green bars. Error bars represent s.e.m.
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brothers already have grandchildren, and both they and
their progeny have no significant health or psychological
issues. The older sister died before P01D was born, likely
from an accident. The other brother died shortly after birth,
for unknown causes. The mother of P01D is over eighty
years old, of good health, apart from high blood pressure,
and has normal intellectual and social abilities.
Patient 01A
Patient 01A (G3 P3 L2) was born at full-term to healthy,
nonconsanguineous parents following an uneventful
birth, at a birth weight of 3400 g. He showed general de-
velopmental delay and was able to walk at the age of
20 months. When examined at the age of 9 years and
5 months, he walked and ran slightly unsteadily and
could not jump with both feet off the ground. He was in
the normal height range when compared to children of
his age, but was slightly slender. In terms of facial features,
he had large ears and a depressed nasal bridge. He was
slightly hypotonic, but had no history of respiratory infec-
tions, has not undergone operations or major medical treat-
ments and has had no seizures or epilepsy. He had no sleep
disturbances, but was often constipated. He occasionally
got a cold, but was not ill very often. He was hospitalized
once at the age of a few months. At the age of 3–4 years,
he generated a couple of words, including “mama” and
“tea”. Currently, he could only say “mama” and had passive
understanding of simple sentences as spoken by his mother,
but no other language or echolalia. He could eat a pear by
himself, but needed to be fed by his mother for meals, dueTable 1 Quantification of developmental, cognitive and autis
Subject
Age at examination










Autism Diagnostic Observation Schedule (ADOS) scores
ADOS communication score
(cutoff score for autism is ≥4)
ADOS social interaction score
(cutoff score for autism is ≥7)
Combined ADOS score (cutoff score for autism is ≥12)to difficulty holding a spoon. He occasionally ran around
with other children, but could not engage in interactive
play. He got very anxious when encountering strangers or
when entering a new environment. When happy, he
clapped his hands.
Cognitive/developmental evaluation using the Bayley
Scales of Infant Development-3 [37] showed that he had
cognitive and language skills, as well as motor skills well
below that for his age (Table 1). This patient, who was
diagnosed with autism using DSM-IV [38] at 4 years and
11 months, had an ADOS score [39] (Table 1) of 20 at
the time of this examination (9 years and 5 months),
well above the cutoff for autistic disorder.
Patient 01B
Patient 01B (G1 P1), the older brother of patient 01A,
was 18 years old at the time of examination. He was of
normal height and weight when compared to his peers.
He had mild dysmorphic features including a depressed
nasal bridge and midface hypoplasia. He had no history
of respiratory infections or other major medical treat-
ments and no history of seizures or epilepsy. He has not
been hospitalized, and is otherwise healthy apart from
an occasional cold. A previous computed tomography
(CT) scan showed no obvious abnormalities. He learnt
to walk at 20 months and currently walked and ran
slightly unsteadily. He liked to walk on his toes, but
could not jump with both feet off the floor. He had no
language, but could passively understand simple phrases
as spoken by his mother. He was able to eat by himself,
and stayed in his room alone at all times other thanm phenotypes of MECP2 duplication-containing patients
P01A P01B
9 years 5 months 18 years
9 months 6 months
15 months 11 months
6 months 5 months
15 months 12 months
15 months 15 months
< 40 < 36
< 40 < 14
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was very excited by wheels. When happy, he put his
hands to his mouth and laughed loudly. He flapped his
hands a lot and did not engage in interaction with
others, but laughed often. Although this patient was
18 years at the time of examination, his cognitive, language
and motor skills were in the range of 6 to 15 months as
measured by Bayley Scales of Infant Development-3 [37]
(Table 1). His ADOS score of 17 [39] was well above the
cutoff for autistic disorder (Table 1).
Parents of the patients P01A and P01B
Since previous publications have shown that female car-
riers of MECP2 duplications had psychiatric symptoms,
the mother of the patients (P01D) completed a Symptom
Checklist-90 [40,41], and both parents completed the
Wechsler Adult Intelligence Scale-Revised [42,43] and the
Broad Autism Phenotype Questionnaire (BAPQ) [44].
Both parents scored in the normal range on the Wechsler
Intelligence Scale (Table 2). In terms of the broad autism
phenotype, both parents scored slightly higher than aver-
age, with the mother scoring further away from the cutoff
score than the father (Table 2). Consistent with a previous
publication [23], the mother of the patients, who also car-
ried the MECP2-containing duplication, had slightly
higher scores in somatization, depression, anxiety and psy-
choticism on completing Symptom Checklist-90 [40,41]
and reported sleep disturbances. She reported no other
healthy issues, and has not had any miscarriages.
Determination of the precise duplication interval by aCGH
To determine the precise size of the MECP2 duplication
and to assay if additional CNVs are present in this fam-
ily, Agilent SurePrint G3 Human CGH Microarray
1x1M was used to assay the entire genome of all four
members of the family (performed by Shanghai Biotech-
nology Corporation, Shanghai, China; see AdditionalTable 2 Clinical summary of the parents of MECP2 duplication
Subject Father (P01C)
Wechsler Adult Intelligence Scale-Revised
Verbal IQ 93
Performance IQ 138
Full Scale IQ 109
Broad Autism Phenotype Questionnaire (cutoff score in brackets)
Aloof Personality (≤3.25) 3.33
Pragmatic language deficits (≤2.75) 3.00
Rigid personality (≤3.50) 3.50
Total score (≤ 3.15) 3.28
Symptom Checklist-90file 1 for details). The MECP2 containing duplication
(151,369,305 – 153,589,577) was found to be 2.22 Mb,
including a large number of genes other than MECP2
(Figure 2). The duplicated region, starting with GABRA3
and ending with FLNA, is the same in the brothers and
their mother, consistent with both brothers inheriting
the CNV from their mother.
Both Patients 01A and 01B also had a 213.7 kb dupli-
cation on Chromosome 2, inherited from their father.
This region contained the genes PFN4, LOC375190,
C2orf84 and ITSN2. None of these genes have been
shown to be associated with autism, and furthermore,
since the father is a healthy, normal adult, this CNV is
unlikely to be disease-causing by itself. Patient 01A had
no other CNVs. Patient 01B had a 48.4 kb duplication
on Chromosome 2, containing no known genes, inher-
ited from the mother, and a small deletion (8.2 kb) at
11q13.5, containing GDPD4, inherited from his father.
In a previous report [45], loss of GDPD4 was found as a
low frequency de novo CNV in autism patients (3 autism
from 1683 analyzed) but not in normal controls. The re-
lationship of GDPD4 to autism is otherwise unknown. In
our study, since the GDPD4-containing CNV in Patient
01B is inherited from a healthy parent, it is unlikely to
be disease-causing by itself.
Since, based on the existing literature, the other
CNVs found in Patients P01A and P01B are unlikely to
be the main cause of the patients’ phenotypes, our
whole genome CNV results provided further evidence
that the main genetic abnormality in patients P01A and
P01B is their MECP2-containing duplication, inherited
from the mother. The other CNVs could also, in
principle, contribute to the patients’ phenotypes in the
background of the MECP2-containing duplication. As
the MECP2-containing duplication region is relatively
large, we also examined whether other genes in the









Slightly high scores in somatization, depression, anxiety,
psychoticism; normal in all other categories
Figure 2 Identification of a 2.22 Mb MECP2 duplication in P01A and P01B, inherited from their mother. Dots represent relative intensities
in log2 ratio and genomic locations of the oligonucleotide probes employed in aCGH assay. For males (P01A, P01B, P01C), green (loss), black (no
change), and red (gain) dots represent log2 ratio deviation from the horizontal line of 0; and for the female (P01D), green (loss), black (no
change), and red (gain) dots represent log2 ratio deviation from the horizontal line of 1. Regions with copy number gains are indicated with red
horizontal bars.
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contained 54 genes, including two subunits of the GABA
receptor (GABRA3, GABRQ), an isocitrate dehydrogen-
ase (IDH3G), interleukin-1 receptor-associated kinase 1
(IRAK1), the L1 cell adhesion molecule (L1CAM), a
PDZ domain protein (PDZD4), Plexin B3 (PLXNB3) and
a creatine transporter (SLC6A8) (More details below).
Estimation of the association level of this group of genes
with autism was carried out using the AutismKB data-
base (http://autismkb.cbi.pku.edu.cn/index.php), an on-
line database that assigned a weighted score to each
gene, CNV or linkage region reported to be associated
with autism, based on published literature [46]. Using this
database, we found that although MECP2 was by far the
gene most associated with autism, with a high score of 26,
many other genes in the interval also contributed from 3
to 12 points, bringing the score of the entire duplicated
region to a very high total of 158 (Additional file 2). The
result of this analysis further underscored the importance
of thisMECP2-containing region to autism.
Size of duplicated region
Compared to other patients with reported duplications
in MECP2, the duplicated region of 2.2 Mb identified in
family P01 is relatively large. The duplication size in the
reported literature is from 0.32 Mb [23] to 2.56 Mb [47].
The centromeric end of the duplication is located in the
3’ untranslated region of GABRA3 (located on the com-
plementary strand), suggesting potential duplication of a
functional copy of the GABRA3 gene. The telomeric end
is within FLNA. Since this gene is also located on the
complementary strand, and thus the 5’ end and pro-
moter regions are outside of the duplicated region, it is
likely that there is no gain-of-function of FLNA. Consist-
ently, the patients did not exhibit the severe, chronic in-
testinal peudo-obstruction phenotype associated with
FLNA duplication [14]. Also worth noting, the telomeric
breakpoint is within the 215 kb region distal to MECP2
that has been previously identified as a genomic interval
prone to rearrangements resulting in MECP2 duplica-
tions [47].
Although a number of genes in the duplication region
have been reported to be associated with autism, the
clinical characteristics of our patients fit well with
patients carrying just MECP2 duplication [15,20,23,47],
the most autism-related gene within the region. IRAK1,
the gene neighboring MECP2 and also included in the
minimum duplication region [15,20,23,47], is a member
of the toll-like receptor-signaling pathway [48] and has
been proposed to contribute to the recurrent infection
phenotype in affected boys [26]. Interestingly, although
P01A and P01B had Xq28 duplications that clearly
included IRAK1, they did not have the recurrent infec-
tions reported in some other patients.Another gene in the duplicated interval with develop-
mental phenotypes is SLC6A8, a creatine transporter
whose loss of function resulted in severe intellectual dis-
ability and autism [49,50]. In other MECP2 duplication
patients, where the duplicated region also included
SLC6A8, creatine levels in spinal fluid and urine were
normal, and there were no additional phenotypes [20].
Similarly, our patients did not report any metabolic
deficiencies.
The other genes in the duplicated interval reported to
be associated with autism are mostly based on CNV
studies, rare mutations found during X-chromosome se-
quencing and/or expression studies (see scores in Add-
itional file 2 and references within the AutismKB
database). Since there are no detailed patient descrip-
tions in these large scale studies, it is difficult to estab-
lish genotype-phenotype relationships for these genes. It
is possible that some of these genes may affect the
patient’s clinical characteristics in the background of
MECP2 duplication. Of particular interest in this group
are GABA receptor subunits GABRA3 and GABRQ,
components of GABAergic neurotransmission. GABA is
the main inhibitory neurotransmitter in the brain, and
alterations of GABAergic signaling are thought to be
associated with ASD [51]. Also of interest are synaptic
components and cell adhesion molecules, which have re-
cently been associated with autism [52]. Duplicated
genes in this category include: L1CAM, encoding the L1
cell adhesion molecule; PDZD4, the PDZ domain con-
taining and potential post-synaptic scaffold protein, and
PLXNB3, the axon guidance molecule Plexin B3, which
acts as a receptor for the Semaphorin 5A signal.Clinical features of boys with duplicated MECP2
Our results are consistent with previous reports showing lack
of correlation between duplication size and clinical pheno-
types, as the patients we identified are no more severe than
those with much smaller duplications [14,15,23,26,27,47].Conclusions
In this study, we identified a Chinese Han family with two
brothers carrying a MECP2-containing duplication inher-
ited from their mother. The duplicated region, as defined
by microarray analysis, was 2.22 Mb in size. To our know-
ledge, this is the first report of Chinese Han autistic
patients with MECP2 duplication. These individuals
shared many characteristics with previously reported
MECP2 duplication patients [9-27], including autism, in-
tellectual disability, hypotonia and mild dysmorphic fea-
tures, but not recurrent respiratory infections or epilepsy.
Identification and characterization of more patients are
needed for studies regarding potential differences in
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relation between duplication size and clinical phenotype.
Importantly, our results demonstrate thatMECP2 duplica-
tion is present in autism patients of Chinese Han ethnicity,
likely at an occurrence rate suitable for genetic testing.
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